| Literature DB >> 29404651 |
M Löbermann1, B Handorn2, A Winkelmann3, E C Reisinger4, H P Hartung5,6, U K Zettl3.
Abstract
In June 2017 the European Court of Justice (ECJ) issued a verdict on the legal assessment of the association between hepatitis B immunization and the subsequent manifestation of multiple sclerosis (MS). This led to a high level of insecurity in the medical field as well as the normal population, especially in MS patients. The aim of this article is to briefly present the evidence-based medical facts and in particular to clearly highlight the legal aspects of the abovenamed ECJ verdict.Entities:
Keywords: Burden of proof; Court verdict; Hepatitis B vaccination; Medicinal products liability; Product liability
Mesh:
Year: 2018 PMID: 29404651 DOI: 10.1007/s00115-018-0492-6
Source DB: PubMed Journal: Nervenarzt ISSN: 0028-2804 Impact factor: 1.214